11.36USD+0.01 (+0.09%)
Market Summary
USD11.36+0.01
0.09%
PHYT Stock Price
View Fullscreen
PHYT RSI Chart
PHYT Valuation
PHYT Price/Earnings (Trailing)
PHYT Profitability
PHYT Fundamentals
PHYT Earnings
Breaking Down PHYT Revenue
Last 7 days
0.5%
Last 30 days
1.9%
Last 90 days
2.4%
How does PHYT drawdown profile look like?
PHYT Financial Health
PHYT Investor Care
Which funds bought or sold PHYT recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
| Apr 23, 2024 | Spartan Fund Management Inc. | sold off | -100 | -1,236 | - | -% |
| Apr 23, 2024 | Spartan Fund Management Inc. | sold off | -100 | -1,010,780 | - | -% |
| Apr 23, 2024 | DUPONT CAPITAL MANAGEMENT CORP | unchanged | - | - | 2,505 | -% |
| Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 100 | 13,911 | 23,430 | -% |
| Feb 26, 2024 | Virtu Financial LLC | added | 3.94 | 5,000 | 116,000 | 0.01% |
| Feb 16, 2024 | Context Capital Management, LLC | unchanged | - | 8,929,000 | 8,936,000 | -% |
| Feb 15, 2024 | Westchester Capital Management, LLC | reduced | -6.71 | -485,091 | 7,687,350 | 0.27% |
| Feb 15, 2024 | Westchester Capital Management, LLC | unchanged | - | 1,499 | 7,999 | -% |
| Feb 14, 2024 | BERKLEY W R CORP | added | 65.03 | 3,015,810 | 7,558,570 | 0.55% |
| Feb 14, 2024 | AQR Arbitrage LLC | unchanged | - | 17,615 | 2,152,890 | 0.09% |
Are Funds Buying or Selling PHYT?
Calls
Puts
Net Call Options
No. of Funds
Unveiling 's Major ShareHolders
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2024 | glazer capital, llc | 3.48% | 487,045 | SC 13G/A | |
| Feb 14, 2024 | balyasny asset management l.p. | 10.30% | 1,442,387 | SC 13G/A | |
| Feb 14, 2024 | first trust capital management l.p. | 5.49% | 768,746 | SC 13G | |
| Feb 14, 2024 | meteora capital, llc | 5.04% | 705,742 | SC 13G | |
| Feb 07, 2024 | adage capital partners gp, l.l.c. | 0% | 0 | SC 13G/A | |
| Feb 01, 2024 | cowen and company, llc | 1.79% | 251,626 | SC 13G |
Recent SEC filings
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Apr 23, 2024 | DEFA14A | DEFA14A | |
| Apr 23, 2024 | 8-K | Current Report | |
| Apr 22, 2024 | 8-K | Current Report | |
| Apr 09, 2024 | DEF 14A | DEF 14A | |
| Apr 01, 2024 | NT 10-K | NT 10-K | |
| Mar 15, 2024 | PRE 14A | PRE 14A | |
| Feb 20, 2024 | 8-K | Current Report | |
| Feb 20, 2024 | 425 | Prospectus Filed | |
| Feb 14, 2024 | SC 13G/A | Major Ownership Report | |
| Feb 14, 2024 | SC 13G/A | Major Ownership Report |
Earnings Report: Key Takeaways & Analysis
Balance Sheet
(In Thousands)
| Balance Sheet | (In Thousands) | |||||||||
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
| Assets | 2.0% | 97,648 | 95,731 | 212,239 | 210,012 | 208,396 | 207,613 | 207,772 | 207,946 | - |
| Current Assets | 222.8% | 538 | 167 | 240 | 361 | 680 | 832 | 1,193 | 1,356 | - |
| Cash Equivalents | 193200.0% | 2.00 | 1* | 658* | 13.00 | 265 | 395 | 732 | 967 | - |
| Liabilities | 0.4% | 13,034 | 12,978 | 12,726 | 11,504 | 12,902 | 15,719 | 18,076 | 20,081 | - |
| Current Liabilities | 59.0% | 1,261 | 793 | 332 | 222 | 81.00 | 72.00 | 502 | 130 | 575 |
| Shareholder's Equity | 1.8% | 97,490 | 95,784 | 211,899 | 209,551 | 207,590 | 206,567 | 206,281 | 206,281 | 5.00 |
| Retained Earnings | -1.4% | -12,896 | -12,712 | -12,386 | -11,043 | -12,097 | -14,673 | -16,586 | -18,416 | -20.38 |
| Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | 24.00 |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | 4,375 |
Cashflow (Last 12 Months)
(In Thousands)
| Cashflow (Quarterly) | (In Thousands) | |||||||||||
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
| Cashflow From Operations | -66.0% | -119 | -71.71 | -12.71 | -227 | -130 | -340 | -231 | -186 | - | - | - |
| Cashflow From Investing | -Infinity% | -320 | - | - | - | - | - | - | - | - | - | - |
| Cashflow From Financing | - | 441 | - | - | 15.00 | - | - | -3.64 | - | - | - | - |
PHYT Income Statement
2023-09-30Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
| General and administrative expenses | $ 547,392 | $ 254,584 | $ 1,574,892 | $ 2,034,395 |
| Loss from operations | (547,392) | (254,584) | (1,574,892) | (2,034,395) |
| Change in fair value of derivative warrant liabilities | 683,395 | 2,830,625 | 202,188 | 8,271,893 |
| Gain on investments held in Trust Account | 1,226,102 | 1,023,730 | 4,723,284 | 1,391,133 |
| Other income | 66 | 83 | ||
| Net income | $ 1,362,105 | $ 3,599,837 | $ 3,350,580 | $ 7,628,714 |
| Class A Ordinary Shares Subject to Possible Redemption | ||||
| Weighted average shares outstanding of ordinary shares, Basic (in Shares) | 8,973,837 | 20,125,000 | 13,589,520 | 20,125,000 |
| Basic and diluted net income per share (in Dollars per share) | $ 0.1 | $ 0.14 | $ 0.18 | $ 0.3 |
| Non-Redeemable Ordinary Shares | ||||
| Weighted average shares outstanding of ordinary shares, Basic (in Shares) | 5,031,250 | 5,031,250 | 5,031,250 | 5,031,250 |
| Basic and diluted net income per share (in Dollars per share) | $ 0.1 | $ 0.14 | $ 0.18 | $ 0.3 |
PHYT Balance Sheet
2023-09-30Condensed Balance Sheets - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| ASSETS | ||
| Cash | $ 1,933 | $ 13,372 |
| Prepaid expenses | 56,180 | 298,422 |
| Extension contribution due from Sponsor | 480,000 | |
| Total current assets | 538,113 | 361,294 |
| Investments and cash held in Trust Account | 97,110,088 | 209,651,193 |
| Total Assets | 97,648,201 | 210,012,487 |
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | ||
| Accounts payable | 63,842 | |
| Promissory note – extension loan | 480,000 | |
| Promissory note – working capital loan | 177,055 | |
| Accrued expenses | 525,209 | 222,020 |
| Total current liabilities | 1,261,106 | 222,020 |
| Deferred underwriting fees payable | 8,443,750 | 8,443,750 |
| Derivative warrant liabilities | 1,314,218 | 1,516,406 |
| Deferred legal fees | 2,034,799 | 1,322,174 |
| Total Liabilities | 13,033,873 | 11,504,350 |
| Commitments and Contingencies (Note 5) | ||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 8,973,837 and 20,125,000 shares at $10.86 and 10.41 per share at September 30, 2023 and December 31, 2022, respectively | 97,490,079 | 209,551,185 |
| Shareholders’ Deficit | ||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ||
| Additional paid-in capital | ||
| Accumulated deficit | (12,896,254) | (11,043,551) |
| Total shareholders’ deficit | (12,895,751) | (11,043,048) |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | 97,648,201 | 210,012,487 |
| Class A Ordinary Shares | ||
| Shareholders’ Deficit | ||
| Ordinary Shares, Value | 503 | |
| Class B Ordinary Shares | ||
| Shareholders’ Deficit | ||
| Ordinary Shares, Value | 503 | |
| Related Party | ||
| ASSETS | ||
| Due from related party | 49,500 | |
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | ||
| Due to related party | $ 15,000 |